{{Drugbox
| IUPAC_name               = 17-(Cyclopropylmethyl)-4-hydroxymorphinan-6-one
| image                    = Ketorfanol.svg
| CAS_number               = 79798-39-3
| CAS_supplemental         = 
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 5490677
| ChemSpiderID             = 16736742
| C = 20 | H = 25 | N = 1 | O = 2
| molecular_weight         = 311.418 g/mol
| smiles                   = C1CC1CN2CCC34CC(=O)CCC3C2CC5=C4C(=CC=C5)O
| StdInChI                 = 1S/C20H25NO2/c22-15-6-7-16-17-10-14-2-1-3-18(23)19(14)20(16,11-15)8-9-21(17)12-13-4-5-13/h1-3,13,16-17,23H,4-12H2/t16-,17+,20-/m0/s1
| StdInChIKey              = ORMBBVGVPWUEMQ-QKLQHJQFSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Ketorfanol''' ([[International Nonproprietary Name|INN]], [[United States Adopted Name|USAN]]) (developmental code name '''SBW-22'''), or '''ketorphanol''', is an [[opioid]] [[analgesic]] of the [[morphinan]] family that was found to possess "potent [[antinociception|antiwrithing]] activity" in [[animal research|animal assay]]s but was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA720|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=720–}}</ref><ref name="Korolkovas1988">{{cite book|author=Andrejus Korolkovas|title=Essentials of Medicinal Chemistry|url=https://books.google.com/books?id=6hxtAAAAMAAJ|date=16 August 1988|publisher=Wiley|isbn=978-0-471-88356-2|page=243}}</ref><ref>{{cite book|title=Chemical Abstracts|url=https://books.google.com/books?id=dmIcAQAAMAAJ|date=4 January 1982|publisher=American Chemical Society|page=22}}</ref> It is a 17-cycloalkylmethyl derivative of morphinan and as such, is closely related structurally to [[butorphanol]], [[cyclorphan]], [[oxilorphan]], [[proxorphan]], and [[xorphanol]], which act preferentially as [[κ-opioid receptor]] [[agonist]]s and to a lesser extent as [[μ-opioid receptor]] [[partial agonist]]s/[[receptor antagonist|antagonist]]s.<ref name="NeumeyerBidlack2000">{{cite journal|last1=Neumeyer|first1=John L.|last2=Bidlack|first2=Jean M.|last3=Zong|first3=Rushi|last4=Bakthavachalam|first4=Venkatesalu|last5=Gao|first5=Peng|last6=Cohen|first6=Dana J.|last7=Negus|first7=S. Stevens|last8=Mello|first8=Nancy K.|title=Synthesis and Opioid Receptor Affinity of Morphinan and Benzomorphan Derivatives:  Mixed κ Agonists and μ Agonists/Antagonists as Potential Pharmacotherapeutics for Cocaine Dependence†|journal=Journal of Medicinal Chemistry|volume=43|issue=1|year=2000|pages=114–122|issn=0022-2623|doi=10.1021/jm9903343}}</ref>

==See also==
* [[Butorphanol]]
* [[Levallorphan]]
* [[Levomethorphan]]
* [[Levorphanol]]
* [[Nalbuphine]]
* [[Xorphanol]]

==References==
{{Reflist|2}}

{{Opioidergics}}

[[Category:Alcohols]]
[[Category:Analgesics]]
[[Category:Ketones]]
[[Category:Morphinans]]
[[Category:Opioids]]


{{analgesic-stub}}